Michelle Stacy, Director at Flex Pharma, Inc. (FLKS), bought 2,585 shares at $9.63 ($25K) on 2016-03-15, disclosed to the SEC on 2016-03-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| IRBT | SELL | 2019-03-01 | $186K | — | Filing → |
| IRBT | SELL | 2019-02-14 | $171K | — | Filing → |
| IRBT | SELL | 2018-08-23 | $155K | — | Filing → |